A study published by the New England Journal of Medicine online suggests that an adult with Type 1 diabetes is better benefited by continuous glucose monitoring of their level of blood sugar with the help of devices as compared to the home testing meters.
Continuous glucose monitoring device was not in favor with younger patients. Manufacturers of this device were hopeful this study could help by bringing them under insurance coverage.
This study was conducted with funds provided by the Juvenile Diabetes Research Foundation which used monitors from Abbot Laboratories and Medtronic Inc. When the body loses its ability to produce insulin which helps in converting blood sugar into energy, the condition called juvenile or Type 1 diabetes occurs.
Study results which were published pushed up the shares of at least three companies on Monday. Market also went on an upswing following an announcement by the US regulators that they were planning on bailing out Freddie Mac and Fannie Mae, the two mortgage lenders who are in trouble for some time now.
Studies were conducted with the help of 322 patients using both continuous glucose monitors and home glucose meters. Statistically significant differences were revealed during the course of these studies.
According to the study authors, for an adult who is motivated to use this technology and integrate it effectively in their diabetes management regime, this device will prove to be very useful. President of the Medtronic’s diabetes business Chris O’Connell said this evidence could be an impetus to insurance companies to provide coverage for such devices.
